Table 3.
Recommended surveillance for individuals with NB predisposition
| Age | Surveillance studies | Frequency |
|---|---|---|
| 0–6 yr. | Abdominal US, Urine VMA and HVA, CXR | Every 3 mo. |
| 6–10 yr. | Abdominal US, Urine VMA and HVA, CXR | Every 6 mo. |
| >10 yr. | No screening recommended |
Abbreviations: CXR, chest radiograph [postanterior (PA) and lateral]; mo., months; yr., years.